Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B B Vargaftig

Showing results (1-10 of 324) with videos related to

Pageof 33
Sort By:
Agents and Actions. Supplements|January 1, 1983
Phospholipids, particularly platelet-activating factor (PAF-acether), in experimental bronchoconstrictionB B Vargaftig
Agents and Actions|December 1, 1973
The pharmacology of slow reacting substance C and of arachidonic acidB B Vargaftig
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 21, 1999
What can we learn from murine models of asthma?B B Vargaftig
European Journal of Pharmacology|August 1, 1978
The inhibition of cyclo-oxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolinesB B Vargaftig
British Journal of Pharmacology|November 1, 1976
Effects of prostaglandin synthetase inhibitors and of other drugs on aggregation of plasma-free rabbit platelets by carrageenan and by thrombin [proceedings]B B Vargaftig
Toxicon : Official Journal of the International Society on Toxinology|January 1, 1982
Platelet activation by non-coagulant snake venom componentsB B Vargaftig
American Journal of Respiratory and Critical Care Medicine|November 14, 1997
Modifications of experimental bronchopulmonary hyperresponsivenessB B Vargaftig
Clinical Reviews in Allergy|January 1, 1994
Paf. A mediator in search of a diseaseB B Vargaftig
Agents and Actions|December 1, 1982
Platelet-activating factor (PAF-acether)B B Vargaftig
Advances in Clinical Pharmacology|January 1, 1974
Recent progress in the pharmacology of kinins with respect to inflammationB B Vargaftig
Pageof 33

Showing results (1-10 of 324) with videos related to

Sort By:
Pageof 33
Agents and Actions. Supplements|January 1, 1983
Phospholipids, particularly platelet-activating factor (PAF-acether), in experimental bronchoconstrictionB B Vargaftig
Agents and Actions|December 1, 1973
The pharmacology of slow reacting substance C and of arachidonic acidB B Vargaftig
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 21, 1999
What can we learn from murine models of asthma?B B Vargaftig
European Journal of Pharmacology|August 1, 1978
The inhibition of cyclo-oxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolinesB B Vargaftig
British Journal of Pharmacology|November 1, 1976
Effects of prostaglandin synthetase inhibitors and of other drugs on aggregation of plasma-free rabbit platelets by carrageenan and by thrombin [proceedings]B B Vargaftig
Toxicon : Official Journal of the International Society on Toxinology|January 1, 1982
Platelet activation by non-coagulant snake venom componentsB B Vargaftig
American Journal of Respiratory and Critical Care Medicine|November 14, 1997
Modifications of experimental bronchopulmonary hyperresponsivenessB B Vargaftig
Clinical Reviews in Allergy|January 1, 1994
Paf. A mediator in search of a diseaseB B Vargaftig
Agents and Actions|December 1, 1982
Platelet-activating factor (PAF-acether)B B Vargaftig
Advances in Clinical Pharmacology|January 1, 1974
Recent progress in the pharmacology of kinins with respect to inflammationB B Vargaftig
Pageof 33